DAYTONA BEACH, FL -- (Marketwire) -- 01/15/13 -- Quture International, Inc. (OTCQB: QUTR) announced today that they will conduct a shareholder conference call on Wednesday, January 23, 2013, at 4:15 p.m. Eastern Standard Time to provide a management update and strategic marketing and sales plan for 2013. Quture's Chairman and CEO, Landon Feazell, will host the call. Shareholders, prospective shareholders, analysts and other interested persons may access the call by dial in fifteen minutes before using one of the following numbers:

1 (888) 895-5271 US Toll Free
1 (847) 619-6547 US Toll
Verbal Pass Code: 34052754

Quture will host quarterly shareholder calls in 2013 after more than one year of being publicly traded. A bisseries of press releases have chronicled the Company's progress and growth. As Quture continues its growth and transition from development of its QualOptima product to marketing and sales, the Company is strategically positioning for success in the healthcare performance and outcomes analytics market. Quture is actively engaged in potential agreements for national and international sales contracts as a Breakthrough Application partner with InterSystems Corporation. Quture is further committed to changing the pedigree of the Company with announced and unannounced additions to the Management Team and key independent contractors. As these transitions mature, the Company has a commitment to our shareholders as well as the investment community for maximum disclosure and communication.

An archived audio replay of the shareholder call will be made available at www.quture.com shortly after the call and be posted for one week.

ABOUT QUTURE INTERNATIONAL, INC. (www.quture.com)
Quture International, Inc. (QUTR) is the proven and experienced performance and outcomes analytics company in the United States. The vision of Quture is to connect all constituents in the global health and health care community to clinically and financially focused and sound data transformed through analytics to knowledge that empowers data-driven decisions for results-driven success. As a "Breakthrough" Application Partner of InterSystems Corporation, Quture's technology for capturing, integrating and aggregating data on the InterSystems Enterprise platform is unequalled. The Company's unique product QualOptima develops a second generation CLINICAL database implementing Quture's core competence of clinical content with evidence-based metrics developed for more than 35 years. QualOptima empowers clinical performance enhancement to achieve optimal patient outcomes. Quture's brand is centered on the value proposition of trust, transparency and independence. As the free enterprise solution to improving health and healthcare while reducing costs, Quture is positioned to become the leading clinical knowledge company in the world. Quture International is a Nevada corporation trading under the symbol QUTR.

This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that a definitive agreement will be completed.